04/20/2022: Lab Alert: FDA Issues Safety Communication about Risk of False Results with Genetic Non-Invasive Prenatal Screening Tests
Audience: Clinical Laboratory Professionals
Level: Laboratory Alert
On April 19, 2022, the U.S. Food and Drug Administration (FDA) issued a safety communication about the risk of false results with genetic non-invasive prenatal screening (NIPS) tests, sometimes called noninvasive prenatal testing or tests (NIPT).
Please review this safety communication in detail and share this message widely with your networks.
For questions, contact us at LOCS@cdc.gov.
Opt in to receive emails from the CDC Laboratory Outreach Communication System (LOCS).
Thank you,
The Laboratory Outreach Communication System
Laboratory Outreach Communication System (LOCS) | Division of Laboratory Systems (DLS)
Center for Surveillance, Epidemiology, and Laboratory Services (CSELS)
Centers for Disease Control and Prevention (CDC)